p53-independent activities of MDM2 and their relevance to cancer therapy
Related Experiment Video
Updated: Aug 19, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
1Department of Pharmacology and Toxicology, Division of Clinical Pharmacology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Abstract:
The feed-back auto-regulatory loop between p53 and MDM2 has been extensively investigated. MDM2 is under the transcriptional control of p53, and MDM2 acts as a negative regulator of p53. There is increasing evidence, however, supporting the notion that MDM2 has activities independent of p53. In the absence of p53, MDM2 may retain its role in cell cycle control, differentiation, cell fate determination, DNA repair, transcription regulation, signal transduction of steroid receptors, cellular response to hypoxia, internalization of surface receptors, and other processes. MDM2 also has oncogenic transformational activities independent of p53. Moreover, anti-MDM2 antisense oligonucleotides have in vitro and in vivo antitumor activity and chemosensitizing and radiosensitizing effects in several human cancer models, regardless of their p53 status. In this article, the p53 independent activities of MDM2 and its interactions with various cellular proteins are considered. The studies reviewed provide a basis for developing novel MDM2 inhibitors as a therapy against human malignancies.
Insights
The MDM2 protein regulates itself via p53, but also performs crucial functions independently of p53. Targeting these p53-independent MDM2 activities offers a promising new strategy for cancer therapy.
Area of Science:
- Molecular Biology
- Cancer Biology
- Biochemistry
Background:
- The feedback loop between p53 and MDM2 is a critical regulator of cellular processes.
- MDM2 is known to negatively regulate p53, forming an auto-regulatory loop.
- Emerging evidence suggests MDM2 possesses functions independent of p53.
Purpose of the Study:
- To review the p53-independent activities of MDM2.
- To explore MDM2's interactions with other cellular proteins.
- To provide a basis for developing novel MDM2-targeted cancer therapies.
Main Methods:
- Literature review of studies on MDM2.
- Analysis of MDM2's roles in various cellular processes.
- Examination of MDM2's oncogenic activities independent of p53.
Main Results:
- MDM2 exhibits p53-independent roles in cell cycle control, differentiation, DNA repair, and more.
- MDM2 possesses oncogenic transformational activities independent of p53.
- Anti-MDM2 therapies show efficacy regardless of p53 status.
Conclusions:
- MDM2 has significant biological functions and oncogenic potential independent of p53.
- Understanding these p53-independent activities is key to developing new cancer treatments.
- Targeting MDM2 offers a therapeutic avenue for various human malignancies.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity
